Background: lower limb vascular injuries are encountered in a vast number of settings, ranging from blast, bullet , stab wounds injuries, to causes as small as blood sampling procedures. Surgery for vascular repair is sometimes indicated without angiography. Broadly speaking, options for repair after assessment of vasculature include simple vessel wall repair, venous patching, resection with end-to-end anastomosis or with inter-positioning graft, bypass graft, ligation or amputation.
Objective: This is the first retrospective trial in our country to examine intrapleural bleomycin in terms of effectiveness, safety, and cost. The aim of this study was to investigate the effectiveness, safety and appropriate mode of administration of intrapleural bleomycin for pleurodesis, in the treatment of malignant pleural effusion. Methods: Between January and July2014, 30 patients presenting to Ibn-alnafees teaching hospital with symptomatic malignant pleural effusions were underwent chemical pleurodesis with bleomycin via bedside thoracostomy. Only the patients with lung re-expansion after drainage entered the study. The conditions of patients were assessed and graded before and after treatment concerning pain, dyspnea, and chest radiographs. Results: Thirty patients who underwent pleurodesis with bleomycin were available for follow-up. The patients demonstrated notable improvement in both pain and dyspnea following treatment. Permanent control of effusions, defined objectively on chest radiograph, was achieved with bleomycin treatments in 21(70%). The procedures were well tolerated and no significant adverse effects were observed. Conclusion: This study confirms that intrapleural bleomycin carries good results in the treatment of malignant pleural effusion. Pleurodesis using bleomycin with 72 hours applied suction should be offered to every patient with malignant pleural effusion, apart from terminally ill ones, provided that a satisfying lung re-expansion has been achieved. A careful selection is essential to define the proper technique.
Objective : To present the advantages of native radio-cephalic AVF creation over native brachio-cephalic AVF creation in patients with chronic renal failure and on regular hemodialysis. Patients : This is a retrospective study of 50 patients for whom native radio-cephalic AVF was created in the upper limb under local anesthesia over a period of about seven years (from 1 st of March 2013 till 1 st of February 2019). Methods: The case sheets of relevant patients for whom an AVF was created were reviewed to collect information like patient's sex, age, site of AVF, type of anastomosis, etc… Results : Native radio-cephalic AVF creation was offered for different age groups and for both sexes. Side to side anastomosis was carried out for most patients and the preferred site was just above the wrist joint on the lateral aspect of forearm between the radial artery and a nearby superficial vein which was mostly the cephalic vein or one of it's tributaries. The time of first cannulation after AVF creation was variable depending on several factors. Different complications but no mortality had been recorded perioperatively. Conclusions : Native radio-cephalic AVF creation is always preferred over native brachio-cephalic AVF creation and every effort was made to search for a suitable distally located superficial vein for the purpose of AVF creation. The region just above the wrist joint on the lateral aspect of forearm was a suitable site for patients with CKD and those with comorbidities because the proximal locations of AVF creation are associated with more complications than the distal ones. Side to side anastomosis for AVF creation was the procedure of choice and the priority was for the non dominant upper limb if possible. ………………………………………………………………..
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.